Skip to main content

Find Clinical Trials

Home
Conditions
DNA Virus Infections

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,913 public trials 504 recruiting studies

Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

NCT04711265

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +20 more
Locations: Partners in Health Research and Development Thika, Kiambu County, Kenya

View Trial Details

Completed

Low-grade Infections of the Intervertebral Discs

NCT04712487

Conditions: Bone Diseases, DNA Virus Infections, Disc Degeneration, +11 more
Locations: Department of Neurosurgery, Kepler University Hospital Linz, Upper Austria, Austria

View Trial Details

Completed

New Methods to Measure the Immune Response to Hepatitis B Vaccine

NCT01821547

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Centre for Clinical Vaccinology & Tropical Medicine (CCVTM) Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

Etiology of Eczema Herpeticum (EH)

NCT03038932

Conditions: DNA Virus Infections, Eczema Herpeticum, Herpes Simplex, +8 more
Locations: National Jewish Health: Division of Pediatric Allergy and Clinical Immunology Denver, Colorado, United States

View Trial Details

Completed

A Study to Evaluate the Mass Balance Absorption and AME of VBR

NCT04637139

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Pharmaron CPC Baltimore, Maryland, United States

View Trial Details

Completed

Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?

NCT01101750

Conditions: Cervical Cancer, Communicable Diseases, DNA Virus Infections, +28 more
Locations: Georgetown University Hospital Washington D.C., District of Columbia, United States

Childrens National Medical Center Washington D.C., District of Columbia, United States

View Trial Details

Completed

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

NCT02482428

Conditions: Communicable Diseases, Condylomata Acuminata, DNA Virus Infections, +17 more
Locations: Novartis Investigative Site Arlington Heights, Illinois, United States

View Trial Details

Completed

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

NCT01474681

Conditions: Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +51 more
Locations: Novartis Investigative Site Minneapolis, Minnesota, United States

View Trial Details

Completed

MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma

NCT02514824

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B

NCT03038113

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Royal Melbourne Hospital Parkville, Victoria, Australia

Linear Clinical Research Limited Nedlands, Western Australia, Australia

Queen Mary Hospital Hong Kong

Prince of Wales Hospital Shatin, New Territories, Hong Kong

View all 19 locations

View Trial Details